Cabozantinib versus everolimus in patients with advanced renal cell carcinoma: Results of the randomized phase 3 METEOR trial Meeting Abstract


Authors: Choueiri, T.; Escudier, B.; Powles, T.; Mainwaring, P.; Rini, B.; Donskov, F.; Hammers, H.; Hutson, T.; Roth, B.; Peltola, K.; Lee, J. L.; Heng, D.; Schmidinger, M.; Borgman-Hagey, A.; Hessel, C.; Scheffold, C.; Schwab, G.; Tannir, N.; Motzer, R.
Abstract Title: Cabozantinib versus everolimus in patients with advanced renal cell carcinoma: Results of the randomized phase 3 METEOR trial
Meeting Title: 18th European Cancer Conference (ECCO 18)
Journal Title: European Journal of Cancer
Volume: 51
Issue: Suppl. 3
Meeting Dates: 2015 Sep 25-29
Meeting Location: Vienna, Austria
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2015-09-01
Start Page: S708
End Page: S709
Language: English
ACCESSION: WOS:000361887403250
PROVIDER: wos
DOI: 10.1016/S0959-8049(16)31927-X
Notes: Meeting Abstract: 4LBA -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer